Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChimeriVax™ Dengue Vaccine in Children Previously Vaccinated Against Yellow Fever (Peru)
NCT00788151Phase 2Completed
- Sponsor
- Sanofi
- Start
- Sep 2008
- Primary completion
- Feb 2010
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of japanese encephalitis chimeric virus vaccine in dengue fever, sponsored by Sanofi. Started Sep 2008; status: completed.
02
Drugs
japanese encephalitis chimeric virus vaccine
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT00788151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00788151.